In recent weeks, members of both the House and Senate have raised questions about the soaring price of — and potential antitrust concerns surrounding — emergency allergy treatment EpiPen. A congressional committee confirmed this morning that it will soon hold a hearing on the issue, and that Heather Bresch, CEO of EpiPen maker Mylan, has been called to testify. [More]
heather bresch
6 Things You Should Know About Heather Bresch, The CEO Behind EpiPen Price Hike
By 8.24.16
As you may have heard, the cost of a life-saving EpiPen from drug maker Mylan increased as much as 600% in just nine years, causing lawmakers and health advocates to call on the drug company — and its CEO Heather Bresch — to lower the cost and provide answers for its increase in the first place. But that could be difficult given the executive’s personal connections not only to the medication, but one legislator. [More]
